Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus
- PMID: 3024973
- PMCID: PMC1167261
- DOI: 10.1002/j.1460-2075.1986.tb04606.x
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus
Abstract
A human cytomegalovirus (HCMV) glycoprotein gene with homology to glycoprotein B (gB) of herpes simplex virus and Epstein-Barr virus and gpII of varicella zoster virus has been identified by nucleotide sequencing. The gene has been expressed in recombinant vaccinia virus and the gene product recognized by monoclonal antibodies and human immune sera. Rabbits immunized with the recombinant vaccinia virus produced antibodies that immunoprecipitate gB from HCMV-infected cells and neutralize HCMV infectivity in vitro. These data demonstrate a role for this protein in future HCMV vaccines.
Similar articles
-
Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.J Virol. 1988 Apr;62(4):1416-22. doi: 10.1128/JVI.62.4.1416-1422.1988. J Virol. 1988. PMID: 2831402 Free PMC article.
-
Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.J Virol. 1992 Jul;66(7):4399-406. doi: 10.1128/JVI.66.7.4399-4406.1992. J Virol. 1992. PMID: 1318410 Free PMC article.
-
Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).J Virol. 1988 Sep;62(9):3309-18. doi: 10.1128/JVI.62.9.3309-3318.1988. J Virol. 1988. PMID: 2841483 Free PMC article.
-
Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.Viruses. 2021 Jun 9;13(6):1106. doi: 10.3390/v13061106. Viruses. 2021. PMID: 34207868 Free PMC article. Review.
-
Recent advances in the identification of significant human cytomegalovirus-encoded proteins.Transplant Proc. 1991 Jun;23(3 Suppl 3):64-9, discussion 69. Transplant Proc. 1991. PMID: 1648839 Review. No abstract available.
Cited by
-
Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial.Int J Hematol. 2017 Feb;105(2):206-212. doi: 10.1007/s12185-016-2110-3. Epub 2016 Oct 28. Int J Hematol. 2017. PMID: 27796740 Clinical Trial.
-
Comparative sequence analysis of human cytomegalovirus strains.J Clin Microbiol. 1991 Nov;29(11):2494-502. doi: 10.1128/jcm.29.11.2494-2502.1991. J Clin Microbiol. 1991. PMID: 1663509 Free PMC article.
-
An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.J Virol. 1999 Oct;73(10):8677-88. doi: 10.1128/JVI.73.10.8677-8688.1999. J Virol. 1999. PMID: 10482621 Free PMC article.
-
Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.J Virol. 2000 Feb;74(3):1383-92. doi: 10.1128/jvi.74.3.1383-1392.2000. J Virol. 2000. PMID: 10627549 Free PMC article.
-
In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.RNA. 2000 Apr;6(4):571-83. doi: 10.1017/s1355838200992215. RNA. 2000. PMID: 10786848 Free PMC article.
References
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical